Bangkok, Thailand
This February our leading instrument for delivering Interval Hypoxic Hyperoxic Therapy – ReOxy is presented to the attention of the general public in Bangkok, Thailand during the 24th Regional Conference of Dermatology taking place from 25th till 28th of February. ReOxy will be hosted by our long-standing Asian partner Indiba Asia at their booth S3 during the trade-show.
Together we look forward to the further promotion of ReOxy-therapy into the day-to-day practice of Thailand healthcare specialists.
ReOxy is CE-marked, approved and intended for improvement of physical exercise capacity in coronary artery disease patients.
